Traditional Chinese medicine preparation for treating coronary heart disease with spleen deficiency and turbid phlegm caused by atherosclerosis
A technology of traditional Chinese medicine preparations and coronary heart disease, which is applied in the field of traditional Chinese medicine preparations for the treatment of coronary heart disease caused by atherosclerosis due to spleen deficiency and phlegm turbidity. , Simple composition, less side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] A granule for coronary heart disease caused by atherosclerosis due to spleen deficiency and phlegm turbidity. The raw materials are formulated according to weight as follows: Astragalus 30g, Codonopsis 30g, Trichosanthes 30g, Pinellia 20g, Atractylodes macrocephala 30g, Poria cocos 30g, Salvia miltiorrhiza 30g, roasted licorice 10g.
[0029] The preparation method of the above-mentioned traditional Chinese medicine granules is as follows: add 10 times the amount of water to the above-mentioned 8 medicinal materials, steam distillation to extract the volatile oil for 4 hours, and collect the distilled aqueous solution and volatile oil in another device; add 8 times the amount of water to decoct the medicinal residues Twice, 2 hours each time, combine the decoction and the distilled aqueous solution, filter, and concentrate to a thick paste (50°C) with a relative density of 1.20-1.22; the ratio of thick paste to dextrin and sucrose is 1:3:1 Mix, add appropriate amount of ...
Embodiment 2
[0031] A granule for coronary heart disease caused by atherosclerosis due to spleen deficiency and phlegm turbidity. The raw materials are formulated as follows by weight: Astragalus 35g, Codonopsis 35g, Trichosanthes mellifera 32g, Banxia 15g, Atractylodes macrocephala 30g, Poria cocos 35g, Salvia miltiorrhiza 30g, roasted licorice 6g.
Embodiment 3
[0033] A granule for coronary heart disease with spleen deficiency and phlegm turbidity caused by atherosclerosis. The raw materials are formulated as follows by weight: Astragalus 40g, Codonopsis 40g, Trichosanthes 40g, Pinellia 18g, Atractylodes macrocephala 38g, Poria cocos 40g, Salvia miltiorrhiza 40g, roasted licorice 5g.
[0034] 1. Clinical trials.
[0035] Using randomized, controlled, double-blind, multi-center superiority clinical trial design, compared with 80 patients in the control group (conventional drug treatment), using the preparation prepared in Example 1 to intervene coronary heart disease with stable angina pectoris · phlegm turbidity and obstruction syndrome 80 patients (ie the test group) were intervened for 12 weeks and followed up for 2 weeks to observe the clinical curative effect of Example 1 on patients with coronary heart disease and angina pectoris. The improvement of patients in the two groups is shown in Table 1; the analysis of the disappearan...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com